Recombinant IGF-1/IGFBP-3 Investigated for Growth Failure in Children with Noonan Syndrome
Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome
Abstract
A research study is investigating recombinant human IGF-1/IGFBP-3 to treat growth failure in children with Noonan syndrome by bypassing GH-IGF axis abnormalities.